Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

SHE:301060 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 18, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,216	3,634	5,323	7,854	13,910	-
Market Cap Growth	-9.50%	-31.73%	-32.23%	-43.54%	-	-
Enterprise Value	3,769	3,446	5,270	7,890	13,408	-
Last Close Price	10.58	8.92	13.01	18.85	33.13	-
PE Ratio	-	-	-	12.72	68.24	-
PS Ratio	2.77	2.09	3.18	1.87	7.82	-
PB Ratio	2.52	2.00	2.69	3.46	8.48	-
P/TBV Ratio	2.72	2.24	3.06	3.86	9.15	-
P/FCF Ratio	11.86	26.01	35.94	-	132.95	-
P/OCF Ratio	10.13	16.80	9.73	93.32	62.23	-
EV/Sales Ratio	2.47	1.98	3.15	1.88	7.54	-
EV/EBITDA Ratio	100.57	-	-	6.96	39.56	-
EV/EBIT Ratio	-	-	-	7.37	45.58	-
EV/FCF Ratio	10.61	24.67	35.58	-	128.15	-
Debt / Equity Ratio	0.12	0.15	0.21	0.11	0.04	-
Debt / EBITDA Ratio	5.47	25.15	-	0.21	0.19	-
Debt / FCF Ratio	0.58	1.96	2.75	-	0.63	-
Net Debt / Equity Ratio	-0.32	-0.30	-0.23	-0.18	-0.43	-0.43
Net Debt / EBITDA Ratio	-22.66	202.84	4.27	-0.37	-2.09	-2.64
Net Debt / FCF Ratio	-1.52	-3.97	-3.06	2.89	-6.76	-4.32
Asset Turnover	0.60	0.62	0.50	1.44	0.99	0.86
Inventory Turnover	3.85	4.18	3.50	8.95	7.72	5.26
Quick Ratio	2.48	2.68	2.31	2.07	3.88	4.96
Current Ratio	3.08	3.25	2.83	2.40	4.28	5.75
Return on Equity (ROE)	-1.97%	-5.19%	-7.61%	37.78%	18.12%	10.93%
Return on Assets (ROA)	-1.07%	-1.39%	-2.89%	22.88%	10.28%	6.89%
Return on Invested Capital (ROIC)	-3.79%	-4.47%	-9.21%	62.87%	28.25%	18.17%
Return on Capital Employed (ROCE)	-2.40%	-3.10%	-7.20%	45.90%	17.40%	12.60%
Earnings Yield	-1.65%	-3.01%	-2.66%	7.86%	1.47%	-
FCF Yield	8.43%	3.84%	2.78%	-1.86%	0.75%	-
Dividend Yield	1.93%	2.24%	-	1.59%	0.91%	-
Payout Ratio	-	-	-	20.35%	0.15%	31.95%
Buyback Yield / Dilution	-0.51%	-0.19%	-1.00%	-13.63%	-0.02%	0.02%
Total Shareholder Return	1.41%	2.05%	-1.00%	-12.04%	0.89%	0.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.